Show simple item record

dc.contributor.authorDwyer, Róisín M.
dc.contributor.authorKerin, Michael J.
dc.date.accessioned2019-09-04T11:13:56Z
dc.date.available2019-09-04T11:13:56Z
dc.date.issued2010-09-30
dc.identifier.citationMesenchymal Stem Cells and Cancer: Tumor-Specific Delivery Vehicles or Therapeutic Targets? (2010). Human Gene Therapy, 21(11), 1506-1512. doi: 10.1089/hum.2010.135en_IE
dc.identifier.issn1557-7422
dc.identifier.urihttp://hdl.handle.net/10379/15386
dc.description.abstractMesenchymal stem cells (MSCs) are a subset of nonhematopoietic multipotent cells found primarily within the bone marrow stroma. The ability of MSCs to specifically home to sites of tumors and their metastases, while escaping host immune surveillance, holds tremendous promise for tumor-targeted delivery of therapeutic agents. Concerns that MSCs may have an inherent capacity for transformation have led to a number of studies investigating their stability in vitro, as significant ex vivo expansion will be necessary to yield the number of cells required for therapeutic applications. MSCs have also been seen to influence the morphology and proliferation of cells within their vicinity through a combination of cell-to-cell interactions and the secretion of chemoattractant cytokines. Understanding interactions between MSCs and tumor cells is required to support realization of their clinical potential. This review discusses MSCs and cancer in terms of (1) potential for transformation and de novo tumor formation, (2) interactions with epithelial cancer cells in tumor establishment, and (3) potential role after engraftment at the site of an established tumor. Elucidation of any potential negative effect of MSCs in the tumor setting will support development of protocols to minimize these effects while taking full advantage of the remarkable tumor-homing capacity of these cells. This review by Drs. Dwyer and Kerin discusses mesenchymal stem cells and cancer in terms of (1) potential for transformation and de novo tumor formation, (2) interactions with epithelial cancer cells in tumor establishment, and (3) potential role after engraftment at the site of an established tumor.en_IE
dc.description.sponsorshipFunding for this work was provided by the Health Research Board of Ireland and National Breast Cancer Research Institute.en_IE
dc.formatapplication/pdfen_IE
dc.language.isoenen_IE
dc.publisherMary Ann Lieberten_IE
dc.relation.ispartofHuman Gene Therapyen
dc.subjectMesenchymal Stem Cellsen_IE
dc.subjectCanceren_IE
dc.titleMesenchymal Stem Cells (MSCs) and cancer: tumour specific delivery vehicles or therapeutic targets?en_IE
dc.typeArticleen_IE
dc.date.updated2019-08-16T10:17:28Z
dc.identifier.doi10.1089/hum.2010.135
dc.local.publishedsourcehttps://doi.org/10.1089/hum.2010.135en_IE
dc.description.peer-reviewedpeer-reviewed
dc.contributor.funderHealth Research Boarden_IE
dc.contributor.funderNational Breast Cancer Research Instituteen_IE
dc.internal.rssid1167661
dc.local.contactRóisín Dwyer, Surgery, Nui Galway. 3008 Email: roisin.dwyer@nuigalway.ie
dc.local.copyrightcheckedYes
dc.local.versionACCEPTED
nui.item.downloads14


Files in this item

Attribution-NonCommercial-NoDerivs 3.0 Ireland
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.

The following license files are associated with this item:

Thumbnail

This item appears in the following Collection(s)

Show simple item record